Status:
COMPLETED
Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer
Lead Sponsor:
UNICANCER
Conditions:
Breast Cancer
Eligibility:
FEMALE
70+ years
Phase:
PHASE2
Brief Summary
RATIONALE: Radiation therapy uses high-energy x rays to kill tumor cells. Giving radiation therapy after surgery may kill any tumor cells that remain after surgery. PURPOSE: This phase II trial is st...
Detailed Description
OBJECTIVES: Primary * Determine reproducibility of localized and concentrated adjuvant radiotherapy, in terms of isodose curve and dose heterogeneity, in older women with stage I or II breast cancer...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of invasive breast cancer
- Stage I or II disease
- Tumor size ≤ 30 mm
- Located in any breast quadrant
- No nodal involvement
- No inflammatory breast cancer
- No positive margins after surgical resection (performed on study)
- No microcalcifications
- Hormone receptor status
- Not specified
- PATIENT CHARACTERISTICS:
- Age
- Over 70
- Sex
- Female
- Menopausal status
- Not specified
- Performance status
- Karnofsky 70-100%
- Life expectancy
- Not specified
- Hematopoietic
- Not specified
- Hepatic
- Not specified
- Renal
- Not specified
- PRIOR CONCURRENT THERAPY:
- Biologic therapy
- Not specified
- Chemotherapy
- Not specified
- Endocrine therapy
- Not specified
- Radiotherapy
- Not specified
- Surgery
- Not specified
Exclusion
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT00104702
Start Date
July 1 2004
End Date
March 1 2011
Last Update
September 4 2013
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Bergonie
Bordeaux, France, 33076
2
Centre Oscar Lambret
Lille, France, 59020
3
Centre Leon Berard
Lyon, France, 69373
4
Centre Antoine Lacassagne
Nice, France, 06088